Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors? - PubMed (original) (raw)

Review

. 2020 Mar;40(3):496-508.

doi: 10.1111/liv.14369. Epub 2020 Jan 13.

Affiliations

Review

Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors?

Jianbin Zhang et al. Liver Int. 2020 Mar.

Abstract

Despite the widespread use of vaccines and antiviral drugs, approximately 350-400 million patients with chronic hepatitis B (CHB) remain worldwide, who carry high risk of cirrhosis and liver carcinoma. Moreover, owing to improvements in global living standards and lifestyle changes, non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease. Coexistence of NAFLD and CHB is commonly observed, especially in Asian CHB populations; however, little is known regarding the relationship between these two diseases as comorbidities. In this review, we summarize recent advances in clinical and basic researches related to the underlying mutual interactions, as well as potential animal models to facilitate further investigation.

Keywords: animal model; chronic hepatitis B; genetic susceptibility; innate immunity; metabolism; non-alcoholic fatty liver disease.

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

PubMed Disclaimer

References

REFERENCES

    1. Liu J, Yang H, Lee M, et al. Distinct seromarkers predict different milestones of chronic hepatitis B progression. Hepatology. 2014;60(1):77-86.
    1. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;373(9663):582-592.
    1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11(2):97-107.
    1. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet. 2003;362(9401):2089-2094.
    1. Isorce N, Lucifora J, Zoulim F, Durantel D. Immune-modulators to combat hepatitis B virus infection: From IFN-alpha to novel investigational immunotherapeutic strategies. Antiviral Res. 2015;122:69-81.

Publication types

MeSH terms

Substances

LinkOut - more resources